Work

Towards the next generation of biomedicines by site-selective conjugation

Year: 2016
Type: review
Abstract: Bioconjugates represent an emerging class of medicines, which offer therapeutic opportunities overtaking those of the individual components. Many novel bioconjugates have been explored in order to address various emerging medical needs. The last decade has witnessed the exponential growth of new site-selective bioconjugation techniques, however very few methods have made the way into human clinical trials. Here we discuss various applications of site-selective conjugation in biomedicines, including half-life extension, antibody-drug conjugates, conjugate vaccines, bispecific antibodies and cell therapy. The review is intended to highlight both the progress and challenges, and identify a potential roadmap to address the gap.
Language: English
Field: Chemistry
Open Access status: hybrid
OpenAlex ID: W2252977645
FWCI: 1.263
Cites: 246
Cited by: 184
Related to: 10